Literature DB >> 7612265

Neurotrophic factors and their receptors.

M Barbacid1.   

Abstract

Several new members of the nerve growth factor family of neurotrophins, which comprises nerve growth factor itself, brain-derived neurotrophic factor and neurotrophins-3, -4 (also known as neurotrophin-5) and -6, have been isolated in recent years. Their signaling receptors have been identified as the Trk family of tyrosine protein kinases, thus facilitating the dissection of the signaling pathways responsible for mediating their trophic properties. More recently, the advent of gene targeting has made it possible to generate strains of mice lacking neurotrophins and their receptors. Analysis of the phenotypes of these mutant animals has provided detailed information on the role that neurotrophins and their receptors play in the ontogeny of the mammalian nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612265     DOI: 10.1016/0955-0674(95)80022-0

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  111 in total

1.  Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression.

Authors:  D Y Choi; J J Toledo-Aral; R Segal; S Halegoua
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor.

Authors:  J C Arevalo; B Conde; B L Hempstead; M V Chao; D Martin-Zanca; P Perez
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Adenovirus vector-directed expression of the neurotrophin-3 receptor (TrkC) in mouse astrocytes.

Authors:  N Rubio; J Abad-Rodriguez
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

4.  Farnesyltransferase inhibitor FTI-277 prevents autocrine growth stimulation of neuroblastoma by BDNF.

Authors:  Rainer Girgert; Josefa Wittrock; Sabine Pfister; Paul Schweizer
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-17       Impact factor: 4.553

5.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

6.  TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death.

Authors:  S Alcántara; J Frisén; J A del Río; E Soriano; M Barbacid; I Silos-Santiago
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

7.  Neurokinin-neurotrophin interactions in airway smooth muscle.

Authors:  Lucas W Meuchel; Alecia Stewart; Dan F Smelter; Amard J Abcejo; Michael A Thompson; Syed I A Zaidi; Richard J Martin; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

Review 8.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 9.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

10.  AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.

Authors:  Radhika Iyer; Carly R Varela; Jane E Minturn; Ruth Ho; Anisha M Simpson; Jennifer E Light; Audrey E Evans; Huaqing Zhao; Kenneth Thress; Jeffrey L Brown; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.